✦ LIBER ✦

Pegaptanib effective in age-related macular degeneration

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of ranibizumab compar

✍ Luis Javier Hernández-Pastor; Ana Ortega; Alfredo García-Layana; Joaquín Girálde 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 240 KB

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PEY17 COST-EFFECTIVENESS OF PEGAPTANIB I

✍ J Javitt; S Wolowacz; N Roskell; S Maciver; S Kelly; A Pleil; G Zlateva 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-Effectiveness Analysis of Ranibizum

✍ Kostas Athanasakis; Vasilios Fragoulakis; Vasiliki Tsiantou; Panagiotis Masaouti 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 551 KB

Pegaptanib in Exudative Age-Related Macu

✍ Steven Schwartz 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 55 KB

Pegaptanib in Exudative Age-Related Macu

✍ Winfried M. Amoaku 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 51 KB